Crinetics supplements proxy disclosures for Vertex USD 85-per-share buyout after shareholder suits
CRNX•Crinetics updates proxy materials after shareholder suits over Vertex deal
Vertex agreed to acquire Crinetics in a merger, leaving Crinetics as a wholly owned Vertex subsidiary.
Crinetics shareholders will vote on the deal at a special meeting scheduled for Aug. 28, 2026.
Three shareholder lawsuits filed Aug. 6 and Aug. 17 allege the proxy materials were misleading, seeking to delay closing or win damages.
Crinetics issued supplemental proxy disclosures on Aug. 18 to address the complaints and shareholder demand letters.
The deal price is USD 85 per share, implying roughly USD 10 billion equity value.
